Atypical femoral fracture in patients with bone metastasis receiving denosumab therapy: a retrospective study and systematic review

BACKGROUND: While denosumab has been shown to prevent skeletal-related events in patients with bone metastasis, there is a concern that it may cause atypical femoral fracture (AFF). While AFF has been reported in patients with osteoporosis receiving denosumab, data are scarce in the context of AFF o...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Momoko, Ozaki, Yukinori, Kizawa, Rika, Masuda, Jun, Sakamaki, Kentaro, Kinowaki, Keiichi, Umezu, Taro, Kondoh, Chihiro, Tanabe, Yuko, Tamura, Nobuko, Miura, Yuji, Shigekawa, Takashi, Kawabata, Hidetaka, Baba, Noriyuki, Iguchi, Haruo, Takano, Toshimi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805596/
https://www.ncbi.nlm.nih.gov/pubmed/31640606
http://dx.doi.org/10.1186/s12885-019-6236-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805596/
https://www.ncbi.nlm.nih.gov/pubmed/31640606
http://dx.doi.org/10.1186/s12885-019-6236-6

Ejemplares similares